OTCMKTS:OTSKF

Otsuka (OTSKF) Stock Price, News & Analysis

Otsuka logo
$77.50 +3.50 (+4.73%)
As of 11/16/2026 09:30 AM Eastern

About Otsuka Stock (OTCMKTS:OTSKF)

Advanced

Key Stats

Today's Range
$77.50
▼
$77.50
50-Day Range
$73.15
▼
$77.50
52-Week Range
$54.26
▼
$79.00
Volume
956 shs
Average Volume
300 shs
Market Capitalization
N/A
P/E Ratio
0.26
Dividend Yield
71.97%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Otsuka Holdings Co., Ltd. is a Japanese healthcare company that oversees the Otsuka Group. Its businesses focus primarily on pharmaceuticals and nutraceuticals, with operations spanning research, development, manufacturing and marketing. The group serves patients, healthcare professionals and consumers in Japan and international markets.

Through its pharmaceutical operations, Otsuka develops and commercializes prescription medicines in areas including psychiatry, nephrology, oncology, cardiovascular disease and other specialty fields. Its portfolio has included products such as Abilify and JINARC, while affiliated companies also provide intravenous fluids, clinical nutrition products and other medical solutions.

Otsuka’s consumer health activities include functional beverages, nutritional products and everyday health foods. Well-known brands associated with the group include Pocari Sweat, CalorieMate and Oronamin C. The group traces its origins to Otsuka Pharmaceutical Factory, founded in Japan in 1921, while Otsuka Pharmaceutical Co., Ltd. was established in 1964 and Otsuka Holdings was formed in 2008 as the group’s holding company.

AI Generated. May Contain Errors.

Otsuka Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
18th Percentile Overall Score

OTSKF MarketRank™: 
0.880980940955 of 5 stars

Otsuka scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Otsuka.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Otsuka is 0.26, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.84.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Otsuka is 0.26, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 33.36.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Otsuka has a short interest ratio ("days to cover") of 999.99, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Otsuka has recently decreased by 33.24%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Otsuka pays a meaningful dividend of 3.45%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Otsuka does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Otsuka is 18.48%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Otsuka's dividend.
  • News Sentiment

    Otsuka has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Otsuka this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Otsuka insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    12.20% of the stock of Otsuka is held by institutions.

  • Read more about Otsuka's insider trading history.
Receive OTSKF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Otsuka and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OTSKF Stock News Headlines

I'm handing you this stock today
Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.tc pixel
Otsuka Corp 9-Mos Net Y49.78B Vs Net Y46.53B
See More Headlines

OTSKF Stock Analysis - Frequently Asked Questions

Otsuka's stock was trading at $54.26 at the beginning of the year. Since then, OTSKF shares have increased by 42.8% and is now trading at $77.50.

Shares of OTSKF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:OTSKF
CIK
1544613
Fax
N/A
Employees
37,758
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
0.26
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (OTCMKTS:OTSKF) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners